National Institutes of Health Clinical Research Training Program

National Institutes of Health Clinical Research Training Program
Name	National Institutes of Health Clinical Research Training Program
Established	1997
Closed	2012
Type	Postgraduate research training
Affiliation	National Institutes of Health
Location	Bethesda, Maryland

Contents

National Institutes of Health Clinical Research Training Program was a two-year postgraduate experiential program based at National Institutes of Health campuses designed to train physician-scientists and clinicians in patient-oriented research. Launched in the late 1990s, it connected trainees with intramural investigators across NIH institutes such as the National Cancer Institute, National Heart, Lung, and Blood Institute, and National Institute of Allergy and Infectious Diseases. The program operated alongside initiatives like the Howard Hughes Medical Institute medical research training programs and complemented clinical research efforts at institutions such as Johns Hopkins University and Mayo Clinic.

History

The program was initiated during the tenure of leaders including Harold Varmus and Elias Zerhouni at the National Institutes of Health and was influenced by national reports from bodies like the Institute of Medicine and commissions associated with the National Academies of Sciences, Engineering, and Medicine. Early cohorts overlapped chronologically with policy initiatives under United States administrations such as the Bill Clinton and George W. Bush presidencies and paralleled training reforms at academic centers like Stanford University and Massachusetts General Hospital. Partnerships were formed with professional societies including the Association of American Medical Colleges and the American Heart Association to align competency expectations. The program evolved during institutional changes at the NIH intramural program and concluded as funding priorities shifted toward alternative pathways such as the Clinical and Translational Science Awards administered by the National Center for Research Resources and later the National Center for Advancing Translational Sciences.

Curriculum elements combined didactics, laboratory rotations, and clinical protocol design with coursework influenced by pedagogy from universities like Yale University, University of California, San Francisco, and Columbia University. Trainees participated in seminars led by principal investigators from institutes such as the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institute of Mental Health, and completed modules on biostatistics and ethics aligned with standards promoted by the World Health Organization and the Food and Drug Administration. The structure emphasized protocol development, data management, and regulatory compliance consistent with guidelines from the Federal Food, Drug, and Cosmetic Act and the Common Rule. Educational content often referenced landmark trials and studies conducted at centers such as Cleveland Clinic and Vanderbilt University Medical Center.

Selection processes mirrored competitive mechanisms used by programs at Harvard Medical School and the Perelman School of Medicine at the University of Pennsylvania, with applicants evaluated by panels including investigators from the National Cancer Institute, National Institute on Aging, and the Johns Hopkins Hospital. Eligible candidates typically included graduates of institutions such as Duke University School of Medicine, University of Michigan Medical School, and UCSF who sought careers in patient-oriented research. Review criteria weighed factors recognized by funders like the National Science Foundation and foundations such as the Robert Wood Johnson Foundation: prior research experience, letters from mentors at places like Brigham and Women's Hospital and Hospital for Special Surgery, and proposed research plans. The program offered stipends comparable to those from fellowships administered by the American Association for the Advancement of Science.

Research projects spanned disease areas championed by institutes including the National Institute of Neurological Disorders and Stroke, National Eye Institute, and National Institute of Arthritis and Musculoskeletal and Skin Diseases. Mentors were drawn from intramural labs led by investigators with profiles similar to Anthony Fauci, Bert Vogelstein, and Francis Collins and collaborations frequently involved clinical units at affiliate hospitals such as Children's National Hospital and Walter Reed National Military Medical Center. Mentorship emphasized translational pathways from bench to bedside, integrating training in clinical trial design, institutional review board processes modeled after Office for Human Research Protections guidance, and grant-writing skills relevant to solicitations from the National Institutes of Health and private funders like the Gates Foundation. Trainees developed and sometimes led investigator-initiated protocols registered in registries analogous to those maintained by the National Library of Medicine.

Alumni produced peer-reviewed articles in journals such as The New England Journal of Medicine, The Lancet, JAMA, and Nature Medicine, and secured career development awards including K-series grants from the National Institutes of Health and awards from organizations like the American Society of Clinical Oncology. Program outputs influenced curricular models at institutions including University of Pennsylvania and Georgetown University and informed national workforce analyses by entities like the National Research Council. The program contributed to clinical trials in oncology, cardiology, infectious disease, and neurology that intersected with large multicenter efforts such as All of Us Research Program initiatives and consortia coordinated by the Centers for Disease Control and Prevention.

Alumni include physician-scientists who subsequently held positions at institutions such as Massachusetts General Hospital, University of California, Los Angeles, Mount Sinai Health System, University of Chicago, and Emory University School of Medicine. Graduates have led trials that impacted guidelines promulgated by organizations like the American College of Cardiology and the Infectious Diseases Society of America, and have been recognized by awards from bodies such as the Paul Ehrlich and Ludwig Darmstaedter Prize committees and the Lasker Foundation. Their work has spanned collaborations with consortia including The Cancer Genome Atlas and public health responses involving the World Health Organization and the Centers for Disease Control and Prevention.

Category:Medical training programs in the United States Category:National Institutes of Health